Skip to main content

Agora
Sign in

House bill · H.R. 9661 (119th Congress)

To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical…

U.S. House of Representatives

Latest action Jul 14, 2026

Sponsor: Nicholas A. Langworthy (U.S. Representative, NY-23, Republican)

Official titleShow

To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.

The heading above is this same sentence with its legal opening removed. No words were added, changed or reordered.

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

There is no summary of this item on Agora. The official record has its full text.

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

2

Cosponsors listed on Congress.gov, shown A to Z.

  • Democratic1
  • Republican1

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

Full history

  1. Jul 14, 2026

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Jul 14, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Jul 14, 2026

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record